| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP006536 |
|
127045-41-4 |
Pazufloxacin - 99% |
0 | C16H15N2O4F | |
| CP002918 |
|
223652-90-2 |
Garenoxacin mesylate hydrate - 99% |
0 | C23H20N2O4F2.CH4O3S.H2O | |
| CP001391 |
|
56974-61-9 |
gabexate mesylate - 98.5% |
0 | C16H23N3O4.CH4O3S | |
| CP005543 |
|
7143-01-3 |
Methanesulfonic anhydride - 98% |
0 | C2H6O5S2 | |
| CP002048 |
|
555-29-3 |
DL-Methyldopa - 99% |
0 | C10H13NO4 | |
| CP000041 |
|
115956-12-2 |
Dolasteron - 98% |
0 | C19H20N2O3 | |
| CP000221 |
|
112811-71-9 |
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester - ≥98.0％ |
0 | C16H15F2NO4 | |
| CP000082 |
|
477600-75-2 |
Tofacitinib - 99% |
0 | C16H20N6O | |
| CP006906 |
|
122111-01-7 |
((2R,3R)-3-(Benzoyloxy)-4,4-difluoro-5-oxotetrahydrofuran-2-yl)methyl benzoate - 99% |
0 | C19H14O6F2 | |
| CP001151 |
|
491-67-8 |
Baicalein - 98% |
0 | C15H10O5 | |
| CP007307 |
|
475207-59-1 |
Sorafenib tosylate - 98.0~102.0% |
0 | C28H24ClF3N4O6S | |
| CP007981 |
|
89250-26-0 |
2-(Chloromethyl)-4-(4-nitrophenyl)thiazole - 70% |
0 | C10H7N2O2SCL | |
| CP000326 |
|
1613220-15-7 |
Niraparib Tosylate - 98% |
0 | C26H30N4O5S | |
| CP002620 |
|
1514-85-8 |
2,2-difluoromalonic acid - 98% |
0 | C3H2F2O4 | |
| CP004391 |
|
121-30-2 |
4-Amino-6-chlorobenzene-1,3-disulfonamide - ≥99.0% |
0 | C6H8ClN3O4S2 | |
| CP000191 |
|
123-11-5 |
4-Methoxybenzaldehyde - 99% |
0 | C8H8O2 | |
| CP003851 |
|
114870-03-0 |
Fondaparinux sodium - 99% |
0 | C31H43N3NA10O49S8 | |
| CP008128 |
|
57-67-0 |
Sulphaguanidine - 99% |
0 | C7H10N4O2S | |
| CP003528 |
|
36983-12-7 |
D-p-Methyl-sulfino phenyl ethyl - 98% |
0 | C12H17NO5S | |
| CP005923 |
|
40258-78-4 |
1-Bromoethyl acetate - ≥97% |
0 | C4H7BrO2 | |
